INS and Hypoglycemia: No patients had acute or persisting sequelae requiring hospitalization from either the insulin‐induced hypoglycemia or fluorouracil and cyclophosphamide treatments nor were there any adverse events that necessitated admission of IV glucose to halt treatment.